The SURPASS clinical trial program demonstrated that tirzepatide at its highest dose (15 mg weekly) produced average weight loss of 20-25% of body weight, significantly exceeding the results seen with GLP-1 only agonists
Brain Sci 13:272 Santos-Garca D, Macas M, Llaneza M, Grande M, De La Fuente-Fernndez R (2011) Serum vitamin B 12 and folate levels in Parkinsons disease patients treated with duodenal levodopa infusion
The BPC-157+TB-500 combo positions itself as a pro-regenerative strategy orthogonal to symptomatic anti-inflammatories, with an opposite mechanistic logic.
These factors include our age, genes, health, environment and lifestyle factors
People may skip workouts, lose motivation, or have more difficulty staying active throughout the day